The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

Under the deal, the Sackler family members will eventually pay a total of $6.5 billion while Purdue will pay $900 million.

Connecticut has joined a new $7.4 billion settlement agreement with OxyContin maker Purdue Pharma and the Sackler family members who own the company.

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The billionaire family that owns Purdue Pharma, maker of the pain medication blamed for helping fuel the nation’s opioid crisis, has agreed to increase payments to settle long-running litigation ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

The Supreme Court on Thursday, June 27, 2024, rejected a nationwide settlement with OxyContin maker Purdue Pharma that would ... The company pleaded guilty to misbranding and fraud charges related ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...